Avara Acquires Consumer Healthcare Facility From GlaxoSmithKline In Aiken, South Carolina

Published: Sep 21, 2017

NORWALK, Conn., Sept. 21, 2017 /PRNewswire/ -- Avara Pharmaceutical Services has signed an agreement with GSK to acquire a GSK consumer healthcare manufacturing facility in Aiken, South Carolina. "This acquisition is an important component of our strategic plan and expands our services by adding additional solid dose capability in the United States, which is in very high demand," stated Timothy C. Tyson, Chairman and CEO. The transaction is expected to complete on or before June 1, 2018.

Tim Tyson, a global leader in the pharmaceutical industry, is Chairman and CEO of Avara Pharmaceutical Services. In his 35-plus year career, Mr. Tyson has negotiated complex multi-billion dollar mergers and acquisitions, led major turn-arounds that have fueled growth and value and, most significantly, has been instrumental in bringing more than 50 lifesaving and life improving medicines to the market.

Avara Pharmaceutical Services is a state-of-the-art contract manufacturing and technical services organization providing both API formulation and manufacturing, along with secondary formulation, manufacturing and packaging of small molecule drugs, including highly potent compounds.  Avara has secondary manufacturing technologies including granulation, coating, blending, encapsulation, compression and drying of tablets and capsules. Avara also has sterile manufacturing capability.

Following completion of the transaction with GSK, Avara Pharmaceutical Services will have seven sites. Three in the US, including the corporate HQs; one in Puerto Rico, one in the UK, one in Ireland, and one in Italy.

  1. Norwalk, CT (USA) Corporate HQ
  2. Arecibo, Puerto Rico  Secondary manufacturing and packaging
  3. Shannon, Ireland  API formulation and manufacturing
  4. Norman, OK (USA) Secondary manufacturing and packaging
  5. Avlon, United Kingdom  API formulation and manufacturing
  6. Liscate, Italy Sterile Manufacturing.
  7. Aiken, South Carolina Secondary manufacturing and packaging

"As we celebrate another important milestone, we continue with great confidence to add pharmaceutical services and capabilities with complementary offerings in key regions in this rapidly growing market. Each of our sites have significant professional experience, state of the art capability and a long history of delivering high quality pharmaceuticals that meet or exceed customer expectations and regulatory requirements in every major market around the world.  The people who are a part of the Avara team are the key to our long-term success," said Tyson. "We are focused on delivering on our commitments and earning the trust of every customer we deal with."

About Avara

Avara Pharmaceutical Services, Inc., based in Norwalk, Connecticut is an international pharmaceutical services company that delivers world-class contract manufacturing and technical services to the pharmaceutical industry. Avara has primary and secondary manufacturing facilities in North America and Europe and supplies products to all major markets around the world.  Avara's broad experience with supply chain, commercialization, product launch and product transfer allow us to sustain exemplary levels of product quality and regulatory compliance. The company is known to exceed customer service level expectations and consistently deliver on time, in full at a fair price. For more information, please visit our website at www.avara.com.

CONTACT: Guy Tiene, 212-366-4455

 

Avara Pharmaceutical Services, Inc. (PRNewsfoto/Avara Pharmaceutical Services,)

View original content with multimedia:http://www.prnewswire.com/news-releases/avara-pharmaceutical-services-acquires-consumer-healthcare-facility-from-gsk-in-aiken-south-carolina-300523688.html

SOURCE Avara Pharmaceutical Services, Inc.

Back to news